• LAST PRICE
    5.7400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    5.5000/ 29
  • Ask / Lots
    5.8100/ 20
  • Open / Previous Close
    0.0000 / 5.7400
  • Day Range
    ---
  • 52 Week Range
    Low 4.0800
    High 6.5291
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 5.61
TimeVolumeKMDA
09:32 ET2605.85
09:34 ET3005.8
09:36 ET29505.82
09:48 ET5005.7974
09:54 ET1985.79
09:57 ET1005.76
10:08 ET1005.7899
10:10 ET1005.7899
10:15 ET1005.7415
10:19 ET1005.74
10:24 ET1005.74
10:39 ET1005.73
10:44 ET1005.736
10:51 ET1005.74
10:57 ET1005.72
11:36 ET1005.735
11:38 ET2005.7235
11:51 ET4605.75
11:58 ET1005.75
12:05 ET18525.76
12:07 ET1005.76
12:09 ET1005.74
12:20 ET1005.745
12:39 ET10005.745
12:50 ET1005.745
12:54 ET2005.75
12:56 ET3005.75
01:10 ET1005.755
01:39 ET4335.74
01:51 ET1005.75
02:02 ET13005.78
02:04 ET1005.78
02:18 ET1005.77
02:20 ET1005.77
02:24 ET1005.77
02:29 ET1005.76
03:00 ET1005.76
03:23 ET30005.78
03:39 ET50735.74
03:41 ET1005.73
03:50 ET19005.735
03:56 ET1005.73
03:59 ET10035.74
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesKMDA
Kamada Ltd
329.9M
32.7x
-22.48%
United StatesSTRO
Sutro Biopharma Inc
350.0M
-2.4x
---
United StatesAGEN
Agenus Inc
240.9M
-0.9x
---
United StatesTVTX
Travere Therapeutics Inc
519.1M
-1.3x
---
United StatesHRTX
Heron Therapeutics Inc
453.4M
-3.5x
---
United StatesTRDA
Entrada Therapeutics Inc
473.2M
22.4x
---
As of 2024-05-09

Company Information

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Contact Information

Headquarters
2 Holtzman St., Science ParkREHOVOT, Israel 7670402
Phone
---
Fax
---

Executives

Chairman of the Board
Lilach Asher Topilsky
Chief Executive Officer
Amir London
Deputy Chairman of the Board
David Tsur
Chief Financial Officer
Chaime Orlev
Senior Vice President - Scientific Affairs
Ruth Wolfson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$329.9M
Revenue (TTM)
$142.5M
Shares Outstanding
57.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.07
EPS
$0.18
Book Value
$4.25
P/E Ratio
32.7x
Price/Sales (TTM)
2.3
Price/Cash Flow (TTM)
15.7x
Operating Margin
7.06%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.